Why can’t you lay down after taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Take TETRACYCLINE (TORQUE) 500MG CAPSULE as advised by your doctor. Lying down right after taking TETRACYCLINE (TORQUE) 500MG CAPSULE can cause oesophagus irritation as well, so don't take it immediately before going to bed.
How long should I take TETRACYCLINE (TORQUE) 500MG CAPSULE?
The usual duration of management is at least 10 days unless otherwise directed by your doctor. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
What precautions have to be taken while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
TETRACYCLINE (TORQUE) 500MG CAPSULE may increase your sensitivity to sunlight and may cause exaggerated sunburns in hypersensitive persons. Avoid exposure to sunlight or ultraviolet light while taking TETRACYCLINE (TORQUE) 500MG CAPSULE and should discontinue therapy at the first sign of skin discomfort.
What should I avoid while taking TETRACYCLINE (TORQUE) 500MG CAPSULE?
Do not take this medicine with food or milk foods such as milk, yogurt, cheese and ice cream at the same time, as they can make the medicine less effective. Contact your doctor for advice.
Can I stop TETRACYCLINE (TORQUE) 500MG CAPSULE if I feel better?
Although it is common to feel better early in the course of therapy, the medication should be taken exactly as directedby your doctor. Do not stop taking TETRACYCLINE (TORQUE) 500MG CAPSULE early as your infection may return if you do not finish the course of this medicine.
Does TETRACYCLINE (TORQUE) 500MG CAPSULE cause diarrhea?
Yes, TETRACYCLINE (TORQUE) 500MG CAPSULE may cause diarrhea. Drink lots of fluids, such as water or fruit juices to keep yourself hydrated. Do not take any medicine on your own for managing diarrhoea. Contact your doctor if your diarrhoea did not improve or suffering from severe or prolonged diarrhoea which may have blood or mucus in it, this may be a sign of serious bowel inflammation.
How long do I need to take TETRACYCLINE (TORQUE) 500MG CAPSULE?How long will TETRACYCLINE (TORQUE) 500MG CAPSULE help me with my diarrhoea?
Your doctor will decide the correct dose and duration for you depending into your overall health and the severity of your symptoms.
IfYes, your doctor may be able to help how how your symptoms may go. The medication will help help manage your symptoms and ensure you are satisfied with your treatment.
Does TETRACYCLINE (TORQUE) 500MG CAPSULE affect the weight?
Healthhires should also be explained to you by your doctor if you may not have or developof oesophageal ulcer or other gastric problems with TETRACYCLINE (TORQUE) 500MG CAPSULE. Contact your doctor if you>:
Can I take TETRACYCLINE (TORQUE) 500MG CAPSULE with food?
TETRACYCLINE (TORQUE) 500MG CAPSULE may take a few weeks to treat oesophageal problems. You may notice a improvement in how you behave when taking TETRACYCLINE (TORQUE) 500MG CAPSULE while you are hydrated, diarrhea is generally normal.
Common Name: Tetracycline HCl; Achromycin V
CAS Number: 64-75-5
Molecular Weight: 480.90
Chemical Formula: C22H24N2O8 • HCl
Solubility: Water
Storage Temperature: Room Temperature
Tetracycline hydrochloride is a hydrochloride salt form of the antibiotic tetracycline. This polyketide antibiotic binds to both the 30S and 50S ribosomal subunits, thus inhibiting proper protein synthesis. Although it is capable of binding to both subunits, the binding at the 30S subunit is more pronounced than that at the 50S. Clinically, tetracycline is used as a broad spectrum antibiotic for a variety of Gram-positive and Gram-negative bacterial infections. Conditions which may indicate for tetracycline administration include upper respiratory infection, typhus fever and rikkettsialpox. It can also be administered to treat severe cases of acne. Tetracycline has played a prominent research role in studies of the efficacy of local antibiotic application in cases of dental trauma. Owing to the fluorescent properties of tetracycline and its ability to bind to bone tissue, this antibiotic is also regularly used in bone histomorphometry studies.
Research or further manufacturing use only, not for food or drug use.
This medication is available in 25 mg, 50 mg, and 100 mg forms. The general U. S. dosage is 2 to 5 times the dose of tetracycline hydrochloride. The general dosage amount of tetracycline hydrochloride can be adjusted within the range of 25 to 400 mg/day by prescription or prescribed by a doctor. Antibiotics are supplied by all medications on the label or by brand-name or generic manufacturers only. These forms are labeled to give the general dosage amount of tetracycline (2 to 5 times the dose). These forms can be used only with severe illness or where dosage adjustment is recommended. No specific instructions can be provided with these forms.See also Side Effects.
This medication may cause birth defects or allergic reactions. The drug is not recommended for the treatment of osteoporosis. Tetracycline is contraindicated in women who are pregnant or plan to become pregnant. Tetracycline may cause live birth in some women. This medication may increase heart rate or blood pressure. Get medical help right away if you have any of the following symptoms. Get medical help right away if you have any of the following symptoms of a heart attack, stroke or heart failure, or if you have any of these symptoms for whichbrand-name medications may be used less often: diarrhea, nausea, vomiting,annotasie,liver disease, slow/irregular heartbeat, fast/irregular breathing, sleep disorders, unusual bleeding/tenderness/pain in the stomach/abdominal/intestines, loss of consciousness, ringing in the ears, numbness/tingling of the arms or hands, pain/tenderness/redness in the limbs, yellowing of the skin/ eyes. This condition may occur 15 to 30 days after stopping tetracycline. Heart disease may also increase tetracycline's effectiveness. Stop giving tetracycline to your child. Tell the doctor/pharmate about all of your health conditions.Note:
Side Effects may occur. If any of the following serious side effects occur, stop giving the antibiotic, and let your doctor know: dark colored urine, fever, muscle aches, painful/painful menstrual periods, severe/irregularITH neurotoxicity ( neurotoxin or encephalopathy ) dark urine, yellowing of the skin/eyes/juniorplex, yellowing of the eyes/skin, yellowing of the face/tongue/throat, severe drowsiness or loss of coordination (rigidity), slow/irregular heartbeat, headache, loss of consciousness, seizures, weakness in one or both legs/chest, vision changes, yellowing of the skin/eyes/juniorplex, cramping/chest pain, or severe confusion, stop giving the drug and let your doctor know if (or when) any of your symptoms get worse.
In very large majority of children, tetracycline is administered orally. The dosage of tetracycline is based on the type of the infection and the clinical response. The typical starting dose is 250 to 500 mg/day. If the clinical response is not satisfactory, the dosage may be increased to 500 mg/day.
The authors reported the outcome of this review. It included all published studies in the PubMed Central database from January 1, 2024 to December 31, 2023. These studies were reviewed for quality, risk of bias, and data collection. Inclusion and exclusion criteria are summarized in.
To reduce the risk of bias, we reviewed the primary and secondary outcomes reported in each of the articles. The primary outcomes in the studies reporting the association between folic acid use and bladder cancer were identified by searching the database using the keywords of “folic acid,” “lactose,” “digoxin,” “diaminobutyric acid (DABA),” “tetracycline,” “tramadol,” “prodrugs,” and “prodrugs/drugs.” The search was limited to articles with limited or no data on the association between folic acid use and bladder cancer. Other outcomes, such as the number of bladder cancer events or the risk of developing bladder cancer were not reported. The risk of developing bladder cancer was reported as the number of bladder cancer events per 100,000 person years (PY).
In the review of the studies reporting the association between folic acid use and bladder cancer, we identified the following:
The primary outcome reported in the studies reporting the association between folic acid use and bladder cancer was the number of bladder cancer events or the risk of developing bladder cancer per 100,000 person years (PY).
The secondary outcomes reported in the studies reporting the association between folic acid use and bladder cancer were:
The primary outcome was the number of bladder cancer events or the risk of developing bladder cancer per 100,000 person years (PY).
The secondary outcomes were:
We also excluded studies that did not report the risk of developing bladder cancer, or studies that did not report the risk of developing bladder cancer. In addition, the studies that reported the risk of developing bladder cancer were excluded, and the incidence of bladder cancer was not reported.
The results of this review are provided in.
To conclude, the results of this review are consistent with those of the review by the following authors. However, the results may be considered preliminary, and further research is required.
To reduce the risk of bias, we identified the primary and secondary outcomes reported in the studies reporting the association between folic acid use and bladder cancer, and reported the number of bladder cancer events or the risk of developing bladder cancer per 100,000 person years (PY).
To reduce the risk of bias, we searched the PubMed Central database for all published reviews in the PubMed Central database (February 2021).
©2023 The Canadian College of Pharmacy, University of Manitoba (Canada) 2017
This publication is an Open Access publication of the Canadian College of Pharmacy, University of Manitoba, Canada.Publication Date:2023-01-012016-02-142017-11-01©2023 The Canadian College of Pharmacy, University of Manitoba, Canada.
Zithromax has been shown to cause some side effects. Talk to your health care provider if these mild reactions do not go away within a few days.
Common side effects reported from Zithromax use include:
This is not a complete list of adverse effects – though these are among the most common.Seek medical attention right away if you experience any of the following symptoms while taking Zithromax:
As with all prescription medication, be sure to inform the prescribing doctor about any medical conditions you have been previously diagnosed with and any medication/ supplements you are currently taking before starting treatment with Zithromax.
Zithromax can interact with other medications and substances, causing potentially serious side effects. These medications and substances include certain anticoagulants (blood thinners), colchicine (Colcrys, Gloperba, Mitigare), cyclosporine (Gengraf, Neoral, Sandimmune), digoxin (Lanoxin), dihydroergotamine (D. H. E. 45, Migranal, Trudhesa); ergotamine (Ergomar, in Migergot), medications for irregular heartbeat such as amiodarone (Nexterone, Pacerone), dofetilide (Tikosyn), procainamide, quinidine, and sotalol (Betapace, Sorine, Sotylize), nelfinavir (Viracept), and phenytoin (Dilantin, Phenytek).
Certain antacids can reduce the effectiveness of Zithromax tablets and Zithromax powder, so you should allow time between taking antacids and your Zithromax dose.
In addition, let your doctor know if you are pregnant or planning on becoming pregnant before starting treatment with this medication.
What else about this medication?If you are taking any other medications, emergency medical care is needed; as this medication can interact with substances, adverse effects, or side effects, it is important to inform your health care provider.
What is Tetracycline?Tetracycline is a type of antibiotic called a macrolide. It is used to treat a wide variety of bacterial infections.
Tetracycline is an antibiotic that works by preventing bacteria from producing the proteins that usually allow the growth and multiplication of healthy bacteria. Tetracyclineaquin is used to treat a wide variety of bacterial infections
Tetracyclineaquin is a type of antibiotic called a macrolide.